Alimera Income Tax Expense vs Gross Profit Analysis
ALIM Stock | USD 3.49 0.18 5.44% |
Alimera Sciences financial indicator trend analysis is way more than just evaluating Alimera Sciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Alimera Sciences is a good investment. Please check the relationship between Alimera Sciences Income Tax Expense and its Gross Profit accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alimera Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Alimera Stock, please use our How to Invest in Alimera Sciences guide.
Income Tax Expense vs Gross Profit
Income Tax Expense vs Gross Profit Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Alimera Sciences Income Tax Expense account and Gross Profit. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Alimera Sciences' Income Tax Expense and Gross Profit is -0.57. Overlapping area represents the amount of variation of Income Tax Expense that can explain the historical movement of Gross Profit in the same time period over historical financial statements of Alimera Sciences, assuming nothing else is changed. The correlation between historical values of Alimera Sciences' Income Tax Expense and Gross Profit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Income Tax Expense of Alimera Sciences are associated (or correlated) with its Gross Profit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Gross Profit has no effect on the direction of Income Tax Expense i.e., Alimera Sciences' Income Tax Expense and Gross Profit go up and down completely randomly.
Correlation Coefficient | -0.57 |
Relationship Direction | Negative |
Relationship Strength | Very Weak |
Income Tax Expense
Gross Profit
Gross profit is a required income statement account that reflects total revenue of Alimera Sciences minus its cost of goods sold. It is profit before Alimera Sciences operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Most indicators from Alimera Sciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Alimera Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alimera Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Alimera Stock, please use our How to Invest in Alimera Sciences guide.At this time, Alimera Sciences' Tax Provision is very stable compared to the past year. As of the 29th of April 2024, Issuance Of Capital Stock is likely to grow to about 85.1 M, while Sales General And Administrative To Revenue is likely to drop 0.22.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 5.4M | 5.9M | 10.2M | 10.7M | Depreciation And Amortization | 2.6M | 2.7M | 8.7M | 9.2M |
Alimera Sciences fundamental ratios Correlations
Click cells to compare fundamentals
Alimera Sciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Alimera Sciences fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 50.3M | 50.9M | 58.5M | 42.6M | 153.5M | 161.2M | |
Short Long Term Debt Total | 39.0M | 44.6M | 43.6M | 44.3M | 67.4M | 70.8M | |
Other Current Liab | 4.7M | 3.2M | 3.4M | 4.0M | 12.8M | 13.5M | |
Total Current Liabilities | 12.0M | 12.3M | 12.6M | 39.7M | 21.9M | 14.3M | |
Total Stockholder Equity | (4.4M) | (8.0M) | (2.6M) | (20.8M) | 46.2M | 48.5M | |
Property Plant And Equipment Net | 2.0M | 2.4M | 4.5M | 3.9M | 3.6M | 3.8M | |
Net Debt | 29.6M | 33.4M | 27.1M | 39.1M | 55.3M | 58.1M | |
Retained Earnings | (387.6M) | (392.9M) | (397.3M) | (415.4M) | (418.5M) | (439.4M) | |
Accounts Payable | 7.1M | 7.5M | 8.7M | 10.1M | 8.3M | 5.0M | |
Cash | 9.4M | 11.2M | 16.5M | 5.3M | 12.1M | 19.3M | |
Non Current Assets Total | 17.6M | 15.9M | 16.4M | 13.2M | 101.1M | 106.2M | |
Non Currrent Assets Other | (16.8M) | (15.2M) | 833K | 183K | 52K | 54.6K | |
Cash And Short Term Investments | 9.4M | 11.2M | 16.5M | 5.3M | 12.1M | 20.5M | |
Net Receivables | 19.3M | 17.2M | 19.1M | 19.6M | 34.5M | 36.3M | |
Common Stock Total Equity | 691K | 701K | 50K | 57K | 65.6K | 62.3K | |
Common Stock Shares Outstanding | 4.8M | 5.1M | 6.6M | 7.0M | 25.6M | 26.8M | |
Liabilities And Stockholders Equity | 50.3M | 50.9M | 58.5M | 42.6M | 153.5M | 161.2M | |
Non Current Liabilities Total | 42.7M | 46.5M | 48.5M | 23.7M | 85.4M | 89.7M | |
Inventory | 1.4M | 2.7M | 2.7M | 1.6M | 1.9M | 1.7M | |
Other Current Assets | 2.6M | 3.7M | 3.8M | 2.9M | 3.9M | 2.5M | |
Other Stockholder Equity | 353.8M | 366.2M | 377.2M | 378.2M | 458.6M | 286.4M | |
Total Liab | 54.8M | 58.8M | 61.1M | 63.5M | 107.4M | 58.0M | |
Property Plant And Equipment Gross | 2.0M | 2.4M | 7.9M | 3.9M | 8.0M | 8.4M | |
Total Current Assets | 32.7M | 34.9M | 42.2M | 29.4M | 52.4M | 42.4M | |
Accumulated Other Comprehensive Income | (1.1M) | (553K) | (1.8M) | (3.0M) | 1.7M | 1.8M | |
Short Term Debt | 255K | 1.7M | 489K | 25.6M | 828K | 786.6K | |
Common Stock | 50K | 57K | 69K | 70K | 524K | 329.8K | |
Other Liab | 3.0M | 3.1M | 3.6M | 2.7M | 2.4M | 2.3M | |
Long Term Debt | 38.7M | 42.4M | 43.1M | 18.7M | 64.5M | 67.7M | |
Property Plant Equipment | 1.4M | 2.0M | 1.6M | 4.5M | 5.2M | 5.4M | |
Net Tangible Assets | (27.6M) | (49.5M) | (39.5M) | (29.1M) | (26.2M) | (27.5M) | |
Other Assets | 1.2M | 734K | 1.5M | 970K | 1.1M | 1.2M | |
Good Will | 18.7M | 16.7M | 14.8M | 12.8M | 14.8M | 14.4M | |
Retained Earnings Total Equity | (399.1M) | (377.1M) | (387.6M) | (392.9M) | (353.6M) | (371.3M) | |
Long Term Debt Total | 34.6M | 38.2M | 38.7M | 42.4M | 48.8M | 51.2M | |
Capital Surpluse | 341.6M | 346.1M | 350.1M | 365.8M | 420.7M | 335.8M |
Pair Trading with Alimera Sciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alimera Sciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alimera Sciences will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Alimera Sciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alimera Sciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alimera Sciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alimera Sciences to buy it.
The correlation of Alimera Sciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alimera Sciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alimera Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alimera Sciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alimera Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Alimera Stock, please use our How to Invest in Alimera Sciences guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for Alimera Stock analysis
When running Alimera Sciences' price analysis, check to measure Alimera Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alimera Sciences is operating at the current time. Most of Alimera Sciences' value examination focuses on studying past and present price action to predict the probability of Alimera Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alimera Sciences' price. Additionally, you may evaluate how the addition of Alimera Sciences to your portfolios can decrease your overall portfolio volatility.
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Transaction History View history of all your transactions and understand their impact on performance | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
Is Alimera Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alimera Sciences. If investors know Alimera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alimera Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.84) | Revenue Per Share 3.159 | Quarterly Revenue Growth 0.875 | Return On Assets (0.01) | Return On Equity (1.59) |
The market value of Alimera Sciences is measured differently than its book value, which is the value of Alimera that is recorded on the company's balance sheet. Investors also form their own opinion of Alimera Sciences' value that differs from its market value or its book value, called intrinsic value, which is Alimera Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alimera Sciences' market value can be influenced by many factors that don't directly affect Alimera Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alimera Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Alimera Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alimera Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.